Xcout Intel
UNIVERSAL BIOSENSORS INC.
Established in 2001 and headquartered in Rowville, Australia, Universal Biosensors, Inc., through its subsidiary Universal Biosensors Pty Ltd, operates as a specialized biosensor technology company. Its core business involves the creation, production, and market introduction of point-of-use devices designed to measure analytes across diverse industries. Within the medical field, the company manufactures and provides Prothrombin Time International Normalized Ratio coagulation test strips, and also acts as a distributor for Siemens' Xprecia Stride Coagulation Analyzer, which is crucial for monitoring individuals undergoing warfarin anticoagulant treatment. For the winemaking sector, UBI produces and distributes Sentia SO2 test strips and supplies the Sentia Analyzer, essential for determining free sulfur dioxide levels in post-fermentation wine. Additionally, the company offers non-diagnostic laboratory services and conducts specific coagulation testing. A key collaboration includes a licensing agreement with LifeScan Global Corporation to develop a biosensor strip and an accompanying meter for detecting and managing diabetes in animals.
Subscribe to see UNIVERSAL BIOSENSORS INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
UNIVERSAL BIOSENSORS INC. at a glance
UNIVERSAL BIOSENSORS INC. is a health care equipment & services company headquartered in Rowville, Australia. It is publicly listed (UBI) with a market capitalisation of $3M. Xcout tracks 6 named people at UNIVERSAL BIOSENSORS INC., including Graham McLean (Non-Executive Chairman).
UNIVERSAL BIOSENSORS INC. leadership
- Graham McLeanNon-Executive Chairman
- David HoeyNon-Executive Director
- Graham A McLeanDirector
- Judith SmithNon-Executive Director
- Marshall HeinbergDirector
- Peter MullinExecutive Director
UNIVERSAL BIOSENSORS INC. competitors
A few of UNIVERSAL BIOSENSORS INC.'s closest competitors — see the full list of competitors and alternatives →
Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East. The company's product portfolio is primarily focused on solutions for sleep and neurological disorders. For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S. for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO). Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler. Other software offerings include HD Digital Video integration and various specialized applications. Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors. Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.
Established in 2010 and based in Leichhardt, Australia, Atomo Diagnostics Limited is a global enterprise focused on the innovation and commercialization of medical devices. The company provides swift-result diagnostic tools designed for various applications, including COVID-19 detection, HIV screening, pregnancy confirmation, and assessing respiratory conditions.
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
i-SENS is a South Korean global healthcare company specializing in the development and production of blood glucose monitoring systems, continuous glucose monitoring systems, and in-vitro diagnostics.
Nova Biomedical is a privately held medical technology company founded in 1976 and headquartered in Waltham, Massachusetts. The company provides innovative analytical instruments, clinical meters, and services for the bioprocessing, clinical, and veterinary industries globally.
Embio Diagnostics is a biotechnology company headquartered in Nicosia, Cyprus, that designs and develops portable, biosensor-based digital devices for rapid testing across various global industries.
Get UNIVERSAL BIOSENSORS INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on UNIVERSAL BIOSENSORS INC. in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access